Patents by Inventor Junhua Deng

Junhua Deng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240152855
    Abstract: Disclosed in the present disclosure is an information-based intelligent quality traceability system for fresh milk, which includes a database module configured to store information of the system, a data encryption module configured to encrypt obtained information, an enterprise information module, a raw material information module, a first measurement module, a destruction information module, a transportation information module, a second measurement module, a processing information module, and a delivery information module. Each information module obtains information, a data decryption module is configured to decrypt obtained information, a vehicle condition analysis module is configured to analyze a relation between a vehicle running condition and product quality, and a data analysis module is configured to analyze the data of the system.
    Type: Application
    Filed: June 2, 2023
    Publication date: May 9, 2024
    Inventors: Qi Yang, Ming HAN, Weihua LIU, Junhua YANG, Juan ZHAO, Xin LI, Wen ZHANG, Yating DENG
  • Publication number: 20240132445
    Abstract: Provided is a GABAA receptor agonist phenol derivative that has a novel structure and better efficacy, can effectively reduce side effects, and is safer for clinical use. Specifically disclosed are a compound as represented by the following formula (I), a stereoisomer and pharmaceutically acceptable salt thereof, a pharmaceutical composition containing same, and an application of the compound or composition of the present invention in the central nervous field, thereby providing more and better choices for medicaments for inducing and/or maintaining anesthesia in animal or human bodies, facilitating sedation and hypnosis, and treating and/or preventing anxiety, nausea, vomiting, migraine, convulsion, epilepsy, neurodegenerative diseases, and central nervous system-related diseases.
    Type: Application
    Filed: January 24, 2022
    Publication date: April 25, 2024
    Applicant: HINYE PHARMACEUTICAL CO., LTD.
    Inventors: Junhua LIU, Xueping LIANG, Haigang JIANG, Hengxin WANG, Lili DENG, Zhilin SONG
  • Publication number: 20180127837
    Abstract: The present invention provides a novel virus-like particle expression vector pTMSCA2C, which is constructed as follows: firstly, using plasmid pTrcHis-MS2 as a starting vector and mutating the base T at position 5 of the gene sequence of MS2 bacteriophage 19mer packaging site on the plasmid pTrcHis-MS2 into C through genetic mutation technologies to obtain a plasmid pTMSC; then, mutating valine which is a amino acid corresponding to the initiation codon on the plasmid pTMSC for encoding the maturase protein of MS2 bacteriophage into methionine to obtain a plasmid pTMSCA; and finally, the gene sequence coding wild type MS2 bacteriophage coat protein, after the removal of the terminator, is linked in series with the gene sequence coding MS2 bacteriophage coat protein comprising histidine-tag which is from a pseudovirus vector pTrcMS, and the gene sequence obtained after linking in series is linked to the plasmid pTMSCA to give pTMSCA2C.
    Type: Application
    Filed: December 22, 2015
    Publication date: May 10, 2018
    Applicant: Chinese Academy of Inspection and Quarantine
    Inventors: Junhua Deng, Shaoqiang Wu, Xiangmei Lin, Yongning Zhang, Jizhou Lv, Chunyan Feng, Caixia Wang